We discuss recent published research on how a vitamin B3 derivative reduces new skin cancer risk, as well as other types of UV damage.
* Oral nicotinamide to reduce actinic cancer: A phase 3 double-blind randomized controlled trial.
By Ralph Turchiano
I have a strong affinity for the sciences which led me to create my sites. My compulsion for the past decade has been reviewing literally every peer-reviewed research article. Which can easily be validated by following my posts. To me, science is where the real news is, as it will mold our destiny beyond that of politics or economics. ;-)